RWM
PRPH

Ritholtz Wealth Management’s ProPhase Labs PRPH Stock Holding History

Ritholtz Wealth Management’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,000
Closed -$4.04K – 1030
2025
Q1 		$4.04K Buy
+1,000
New +$4.59K ﹤0.01% 921
2023
Q3 		– Sell
-2,339
Closed -$170K – 736
2023
Q2 		$170K Sell
2,339
-222
-9% -$18.1K 0.01% 631
2023
Q1 		$195K Sell
2,561
-43
-2% -$3.47K 0.01% 604
2022
Q4 		$251K Buy
2,604
+536
+26% +$57.9K 0.01% 494
2022
Q3 		$233K Buy
+2,068
New +$241K 0.01% 617

Other funds holding PRPH

SC
Sykon Capital Harrison, New York $300M AUM 16.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CD
Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Ritholtz Wealth Management's PRPH Position: Q2 2025 in Review

Ritholtz Wealth Management sold out of ProPhase Labs (PRPH) in Q2 2025, closing a stake of 1,000 shares — an estimated $4.04K sold.

Ritholtz Wealth Management first reported a position in PRPH in Q3 2022 and held it in 5 quarters. The position peaked at $251K in Q4 2022. 33 funds tracked by Wall St. Rank hold PRPH as of Q2 2025.

  • Ritholtz Wealth Management reported no remaining ProPhase Labs position as of Q2 2025 after selling out during the quarter.
  • Ritholtz Wealth Management sold 1,000 ProPhase Labs shares in Q2 2025, an estimated $4.04K.
  • Ritholtz Wealth Management first reported a position in ProPhase Labs in Q3 2022 and held it in 5 quarters.
  • Ritholtz Wealth Management's ProPhase Labs position peaked at $251K in Q4 2022.
  • 33 funds tracked by Wall St. Rank held ProPhase Labs as of Q2 2025.

Based on Ritholtz Wealth Management's 13F filing for Q2 2025, filed 28 Jul 2025.